Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL762P is a pseudogene derived from the 7SL RNA gene, a crucial structural noncoding RNA involved in the signal recognition particle (SRP) ribonucleoprotein complex[3][5][4]. Pseudogenes are generally nonfunctional relics of once-functional genes that persist in the genome but do not code for a biologically active product[4]. RN7SL762P does not produce a functional RNA or protein, is not a receptor/enzyme/transporter, and is not considered a therapeutic target. The 7SL RNA parent gene functions as part of SRP to regulate protein targeting to the endoplasmic reticulum[1][6], but RN7SL762P only shares sequence similarity without functional activity. There is no evidence this pseudogene has a role in disease, is regulated as a biomarker, interacts with drugs, or presents notable safety issues for therapeutic development. RN7SL762P should *not* be considered a drug, diagnostic, or therapeutic target in molecular pharmacology or disease research. Its listing as a "target" is incorrect, as it lacks the necessary biological activities[4][5].
None known; not targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 762, pseudogene (RN7SL762P).